Multiple sclerosis: Generic glatiramer acetate-a step toward cheaper MS drugs?

Authors
Category Primary study
JournalNature reviews. Neurology
Year 2016
A randomized, double-blind, phase III trial of generic glatiramer acetate has shown equivalent efficacy and safety compared with the approved formulation, Copaxone. The impact of approval of generic glatiramer acetate, however, will mainly depend on the pricing of the drug.
Epistemonikos ID: 18d61dbb67aebfcc9a73fa262fe788976ae4c163
First added on: Sep 03, 2023